Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
721 8 |
Ultima descărcare din IBN: 2023-11-17 11:39 |
Căutarea după subiecte similare conform CZU |
619:615.254.015.4+619:616.61-002:636.7 (1) |
Științe medicale. Medicină (11143) |
Medicamentele potrivit acţiunii lor principale (395) |
Patologia sistemului urogenital. Boli urinare şi sexuale (genitale) (392) |
Câini (50) |
SM ISO690:2012 STARCIUC, Nicolae, MACRII, V., OSADCI, Natalia, CODREANU, M., ŞENDREA, E., CODREANU, Iuliana, TURCITU, M.. Cercetări privind eficienţa norfloxacinei in tratamentul nefritelor la caine. In: Ştiinţa Agricolă, 2008, nr. 1, pp. 71-73. ISSN 1857-0003. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Ştiinţa Agricolă | ||||||
Numărul 1 / 2008 / ISSN 1857-0003 /ISSNe 2587-3202 | ||||||
|
||||||
CZU: 619:615.254.015.4+619:616.61-002:636.7 | ||||||
Pag. 71-73 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
The efficiency of different antibacterial substances in small animals practice became a very important element in veterinary pharmacotherapeutics. Dogs’ kidney diseases, taking into account their incidence and severity, are situated in front of the list. Inflammatory diseases at dogs have a complex etiology (sometimes associated) and increased multiple clinical features, which involve serious therapeutically and curative troubles for clinicians. The aimof this study it was to evaluate the curative efficiency of norfloxacin in kidneys diseases of dogs. This drug is conditioned by different therapeutical preparations (injectable or oral administration) and comfortable periods between administrtations, and also its well known bioavailability in urinary structures seems to be the main reason in the recommendation for the treatment of kidney diseases. This study was performed on 31 dogs with different inflammatory kidney diseases and different clinical features after treatments with norfloxacin using injectable (batch No.1) or oral (batch No.2) administrations. The curative efficiency registered after injectable treatments was of 85,7% (n = 12, after oral administrations of 70,5% (n = 14). |
||||||
Cuvinte-cheie Curative efficiency, Inflammatory kidney disease, Norfloxacin., Dogs |
||||||
|